The A2aR Adenosine Receptor Controls Cytokine Production in INKT Cells

Overview

Journal Eur J Immunol

Specialty Allergy & Immunology

Date 2009 Dec 30

PMID 20039304

Citations 40

Authors

Michael Nowak

Lydia Lynch

Simon Yue

Akio Ohta

Michail Sitkovsky

Steven P Balk

Mark A Exley

Affiliations

Soon will be listed here.

Abstract

The purine nucleoside adenosine is an important anti-inflammatory molecule, inhibiting a variety of immune cells by adenosine receptor-mediated mechanisms. Invariant NKT (iNKT) cells recognize glycolipids presented on CD1d molecules and produce vigorous amounts of cytokines upon activation, hence regulating immune reactions. The mechanisms polarizing their cytokine pattern are elusive. Previous studies demonstrated that adenosine can suppress IFN-gamma production by iNKT cells. We describe the expression of all four known adenosine receptors A1R, A2aR, A2bR and A3R on mouse iNKT cells. We show that IL-4 production in primary mouse iNKT cells and a human iNKT line is efficiently inhibited by A2aR blockade with an inverse relation to IL-4. These data are supported by A2aR-deficient mice, which exhibit largely decreased levels of IL-4, IL-10 and TGF-beta concomitantly with an increase of IFN-gamma upon alpha-galactosylceramide administration in vivo. While A2aR inhibits other lymphocyte populations, A2aR is required for the secretion of IL-4 and IL-10 by iNKT cells. These data suggest adenosine:A2aR-mediated mechanisms can control the cytokine secretion pattern of iNKT cells.

Citing Articles

Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.

Ramos-Ramirez M, Caballe-Perez E, Lucio-Lozada J, Romero-Nunez E, Castillo-Ruiz C, Dorantes-Sanchez L Cancer Metastasis Rev. 2025; 44(1):30.

PMID: 39915358 DOI: 10.1007/s10555-025-10245-7.

Adenosine-mediated immune responses in inflammatory bowel disease.

Vuerich M, Nguyen D, Ferrari D, Longhi M Front Cell Dev Biol. 2024; 12:1429736.

PMID: 39188525 PMC: 11345147. DOI: 10.3389/fcell.2024.1429736.

Symbiotic combination of and inosine alleviates alcohol-induced liver injury by modulating gut dysbiosis and immune responses.

Wei L, Pan Y, Guo Y, Zhu Y, Jin H, Gu Y Front Microbiol. 2024; 15:1355225.

PMID: 38572243 PMC: 10987824. DOI: 10.3389/fmicb.2024.1355225.

Adenosine, bridging chronic inflammation and tumor growth.

Chen L, Alabdullah M, Mahnke K Front Immunol. 2023; 14:1258637.

PMID: 38022572 PMC: 10643868. DOI: 10.3389/fimmu.2023.1258637.

AR eGFP reporter mouse enables elucidation of AR expression dynamics during anti-tumor immune responses.

Todd K, Lai J, Sek K, Huang Y, Newman D, Derrick E Nat Commun. 2023; 14(1):6990.

PMID: 37914685 PMC: 10620403. DOI: 10.1038/s41467-023-42734-0.

References

Wilson J, Ross W, Agbai O, Frazier R, Figler R, Rieger J . The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol. 2009; 182(8):4616-23. PMC: 2989878. DOI: 10.4049/jimmunol.0801279. View

Coquet J, Chakravarti S, Kyparissoudis K, McNab F, Pitt L, McKenzie B . Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A. 2008; 105(32):11287-92. PMC: 2516267. DOI: 10.1073/pnas.0801631105. View

Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K . Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol. 2001; 166(10):6012-8. DOI: 10.4049/jimmunol.166.10.6012. View

Grever M, Siaw M, Coleman M, Whisler R, Balcerzak S . Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine. J Immunol. 1983; 130(1):365-9. View

DAndrea A, Goux D, de Lalla C, Koezuka Y, Montagna D, Moretta A . Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur J Immunol. 2000; 30(6):1544-50. DOI: 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I. View

Exley M, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G . Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. Eur J Immunol. 2008; 38(6):1756-66. PMC: 2864538. DOI: 10.1002/eji.200737389. View

Emoto M, Kaufmann S . Liver NKT cells: an account of heterogeneity. Trends Immunol. 2003; 24(7):364-9. DOI: 10.1016/s1471-4906(03)00162-5. View

Linden J . Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001; 41:775-87. DOI: 10.1146/annurev.pharmtox.41.1.775. View

Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky M . Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem. 1997; 272(41):25881-9. DOI: 10.1074/jbc.272.41.25881. View

10.

Hasko G, Pacher P . A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol. 2007; 83(3):447-55. PMC: 2268631. DOI: 10.1189/jlb.0607359. View

11.

Thiel M, Caldwell C, Sitkovsky M . The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect. 2003; 5(6):515-26. DOI: 10.1016/s1286-4579(03)00068-6. View

12.

Ring S, Oliver S, Cronstein B, Enk A, Mahnke K . CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J Allergy Clin Immunol. 2009; 123(6):1287-96.e2. DOI: 10.1016/j.jaci.2009.03.022. View

13.

Deaglio S, Dwyer K, Gao W, Friedman D, Usheva A, Erat A . Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007; 204(6):1257-65. PMC: 2118603. DOI: 10.1084/jem.20062512. View

14.

Fredholm B, IJzerman A, Jacobson K, Klotz K, Linden J . International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001; 53(4):527-52. PMC: 9389454. View

15.

Gumperz J, Miyake S, Yamamura T, Brenner M . Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med. 2002; 195(5):625-36. PMC: 2193772. DOI: 10.1084/jem.20011786. View

16.

Godfrey D, McCluskey J, Rossjohn J . CD1d antigen presentation: treats for NKT cells. Nat Immunol. 2005; 6(8):754-6. DOI: 10.1038/ni0805-754. View

17.

Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S . Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992; 176(6):1693-702. PMC: 2119469. DOI: 10.1084/jem.176.6.1693. View

18.

Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K . Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology. 2008; 48(3):841-52. PMC: 2929828. DOI: 10.1002/hep.22401. View

19.

Lappas C, Day Y, Marshall M, Engelhard V, Linden J . Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med. 2006; 203(12):2639-48. PMC: 2118143. DOI: 10.1084/jem.20061097. View

20.

Csoka B, Himer L, Selmeczy Z, Vizi E, Pacher P, Ledent C . Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 2008; 22(10):3491-9. PMC: 2537430. DOI: 10.1096/fj.08-107458. View